The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
| Autor: | Finn, Richard S, Crown, John P, Lang, Istvan, Boer, Katalin, Bondarenko, Igor M, Kulyk, Sergey O, Ettl, Johannes, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav, Thummala, Anu R, Voytko, Nataliya L, Fowst, Camilla, Huang, Xin, Kim, Sindy T, Randolph, Sophia, Slamon, Dennis J |
|---|---|
| Zdroj: | In Lancet Oncology January 2015 16(1):25-35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|